Clinical Trial: Effect of Vericiguat on Acute Coronary Syndrome( ACS?Patients With Ejection Fraction <45%
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Acute Coronary Syndrome
Study Type: OBSERVATIONAL
Official Title: Vericiguat in Patients With Acute Coronary Syndrome and Reduced Ejection Fraction: The EVE-ACSrEF Study
Brief Summary:
Investigators evaluate whether differences exsit in acute coronary syndrome?ACS? patients with ejection <45% between participants who take vericiguat regularly and those who donot.
Read more